Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as <i>Plasmodium</i> Cytoplasmic Prolyl-tRNA Synthetase Inhibitors
Masanori Okaniwa, Akira Shibata, Atsuko Ochida, Yuichiro Akao, Karen L. White, David M. Shackleford, Sandra Duffy, Leonardo Lucantoni, Sumanta Dey, Josefine Striepen, Tomas Yeo, Sachel Mok, Anna Caroline Campos Aguiar, Angelika Sturm, Benigno Crespo, Laura M. Sanz, Alisje Churchyard, Jake Baum, Dhélio B. Pereira, Rafael V. C. Guido, Koen J. Dechering, Sergio Wittlin, Anne‐Catrin Uhlemann, David A. Fidock, Jacquin C. Niles, Vicky M. Avery, Susan A. Charman, Benoı̂t Laleu
Abstract
PRS.
Topics & Concepts
Plasmodium falciparumMalariaBiologyPlasmodium vivaxDrug resistanceIn vitroPharmacologyIC50BiochemistryMicrobiologyImmunologyHIV/AIDS drug development and treatmentRNA and protein synthesis mechanismsPneumocystis jirovecii pneumonia detection and treatment